| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,508,990 | 5,700,904 | 5,541,391 | 5,367,212 | | Cost of Revenue | 2,101,504 | 2,190,005 | 2,173,390 | 2,147,575 | | | Gross Profit | 3,407,486 | 3,510,899 | 3,368,001 | 3,219,637 | | | Operating Expenses | | Research Development | 641,643 | 733,341 | 704,572 | 682,210 | | Selling General and Administrative | 882,252 | 917,353 | 1,015,865 | 959,462 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,883,591 | 1,860,205 | 1,647,564 | 1,577,965 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,210 | (1,024,858) | 21,219 | 57,536 | | Earnings Before Interest And Taxes | 1,889,801 | 835,347 | 1,668,783 | 1,635,501 | | Interest Expense |
-
|
-
|
-
| (387) | | Income Before Tax | 1,889,801 | 835,347 | 1,668,783 | 1,635,888 | | Income Tax Expense | 466,973 | 452,905 | 378,844 | 388,497 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,422,828 | 382,442 | 1,289,939 | 1,247,391 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,422,828 | 382,442 | 1,289,939 | 1,247,391 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,422,828 | $382,442 | $1,289,939 | $1,247,391 |
|
0.45% Nasdaq 
0.20%
Income Statement
